- Home
- MDGL vs WFRD Comparison
MDGL vs WFRD Comparison
Compare MDGL & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- WFRD
- Stock Information
- Founded
- MDGL 2011
- WFRD 1941
- Country
- MDGL United States
- WFRD United States
- Employees
- MDGL N/A
- WFRD N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- WFRD Metal Fabrications
- Sector
- MDGL Health Care
- WFRD Industrials
- Exchange
- MDGL Nasdaq
- WFRD Nasdaq
- Market Cap
- MDGL 6.4B
- WFRD 5.4B
- IPO Year
- MDGL N/A
- WFRD N/A
- Fundamental
- Price
- MDGL $340.14
- WFRD $70.31
- Analyst Decision
- MDGL Buy
- WFRD Strong Buy
- Analyst Count
- MDGL 14
- WFRD 8
- Target Price
- MDGL $351.67
- WFRD $140.50
- AVG Volume (30 Days)
- MDGL 392.5K
- WFRD 877.7K
- Earning Date
- MDGL 02-26-2025
- WFRD 02-05-2025
- Dividend Yield
- MDGL N/A
- WFRD 1.42%
- EPS Growth
- MDGL N/A
- WFRD 51.37
- EPS
- MDGL N/A
- WFRD 7.14
- Revenue
- MDGL $76,813,000.00
- WFRD $5,534,000,000.00
- Revenue This Year
- MDGL N/A
- WFRD $10.75
- Revenue Next Year
- MDGL $195.95
- WFRD $0.79
- P/E Ratio
- MDGL N/A
- WFRD $9.85
- Revenue Growth
- MDGL N/A
- WFRD 11.08
- 52 Week Low
- MDGL $168.25
- WFRD $66.23
- 52 Week High
- MDGL $368.29
- WFRD $135.00
- Technical
- Relative Strength Index (RSI)
- MDGL 61.81
- WFRD 42.88
- Support Level
- MDGL $266.44
- WFRD $68.46
- Resistance Level
- MDGL $343.97
- WFRD $75.27
- Average True Range (ATR)
- MDGL 20.88
- WFRD 2.71
- MACD
- MDGL 2.00
- WFRD 0.43
- Stochastic Oscillator
- MDGL 92.59
- WFRD 29.10
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.